Drugs / AML Cell Vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02493829 | May 2017 → May 2020 | acute myeloid leukemia, myelodysplastic syndrome | King's College London | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AML Cell Vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02493829 ↗ |
| Modality | Vaccine | “Leukaemia Cell Vaccine” NCT02493829 ↗ |